- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06757790
Predictors of Primary Ceaseran Section At Women Health Hospital
Study Overview
Status
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Mina Mikhail Mina Mikhail labib melk
- Phone Number: +201069064059
- Email: drminamikhail13@gmail.com
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
The study will be conducted at Women's Health Hospital in Assiut University, Department of Obstetrics and Gynecology.
divided into 2 groups :females had primary ceaseran section for case and primary vaginal delivery for control group
Description
a. Inclusion criteria:
- All pregnant women underwent primary ceaseran section
- All primiparous women delivered vaginally b. Exclusion criteria:
(1) any women done previous one or more ceaseran section before (2) All pregnant women delivered vaginally before more than one time (2) women had previous uterine scar as hysterectomy, myomectomy (4) any female refused to participate
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Primary ceaseran section women
A comparison between primary ceaseran section women and primary vaginally delivery women to determine predictors of primary ceaseran section
|
A comparison between primary ceaseran section women and primary vaginally delivery women to determine predictors of primary ceaseran section
|
|
Primary vaginally delivery women
A comparison between primary ceaseran section women and primary vaginally delivery women to determine predictors of primary ceaseran section
|
A comparison between primary ceaseran section women and primary vaginally delivery women to determine predictors of primary ceaseran section
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identify the risk factors of primary ceaseran section
Time Frame: Baseline
|
Identify the risk factors of primary ceaseran section and it's predictors among women seeking delivery care in women health hospital
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Highlight the most important preventable factors of ceaseran section
Time Frame: Baseline
|
Highlight the most important preventable factors that may help decrease rate of ceaseran section in Egypt
|
Baseline
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Predictors of ceaseran section
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.